4.7 Article

Altered gene expression and function of peripheral blood natural killer cells in children with autism

Journal

BRAIN BEHAVIOR AND IMMUNITY
Volume 23, Issue 1, Pages 124-133

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2008.08.001

Keywords

Autism spectrum disorder; Natural killer cells; Innate immunity; Cytotoxic proteins; Immunology; Genes

Funding

  1. NIEHS Children's Center [2 P01 ES011269, R01ES015359]
  2. US EPA STAR [R833292, R829388]
  3. Cure Autism Now Foundation
  4. Peter Emch Foundation
  5. Ted Lindsey Foundation
  6. UC Davis M.I.N.D. Institute
  7. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, R01ES015359] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Immune related abnormalities have repeatedly been reported in autism spectrum disorders (ASD), including evidence of immune dysregulation and autoimmune phenomena. NK cells may play an important role in neurodevelopmental disorders such as ASD. Here we performed a gene expression screen and cellular functional analysis on peripheral blood obtained from 52 children with ASD and 27 typically developing control children enrolled in the case-control CHARGE study. RNA expression of NK cell receptors and effector molecules were significantly upregulated in ASD. Flow cytometric analysis of NK cells demonstrated increased production of perforin, granzyme B, and interferon gamma (IFN gamma) under resting conditions in children with ASD (p < 0.01). Following NK cell stimulation in the presence of K562 target cells, the cytotoxicity of NK cells was significantly reduced in ASD compared with controls (p < 0.02). Furthermore, under similar stimulation conditions the presence of perforin, granzyme B, and IFN gamma in NK cells from ASD children was significantly lower compared with controls (p<0.001). These findings suggest possible dysfunction of NK cells in children with ASD. Abnormalities in NK cells may represent a susceptibility factor in ASD and may predispose to the development of autoimmunity and/or adverse neuroimmune interactions during critical periods of development. (c) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available